Join the 'Polymyositis/Dermatomyositis' group to help and get support from people like you.
Posted 27 Nov 2011 by Drugs.com
FRIDAY, Nov. 25 – Patients hospitalized for autoimmune disorders, like rheumatoid arthritis or Crohn's disease, may be at greater risk for a life-threatening pulmonary embolism, a clot in a main artery of the lung, a new study finds. Reporting online Nov. 25 in The Lancet, researchers warned that steps should be taken to prevent this condition among patients admitted to the hospital for autoimmune diseases. In conducting the study, researchers analyzed data on more than 500,000 patients admitted to the hospital in Sweden for one of 33 autoimmune diseases, which can also include Grave's disease, Hashimoto's thyroiditis and chronic rheumatic heart disease. The team, led by Dr. Bengt Zoller of Malmo University Hospital in Sweden, found the overall risk of pulmonary embolism in the 12 months following hospitalization to be six times higher for patients with autoimmune diseases than for ... Read more
Related support groups: Rheumatoid Arthritis, Crohn's Disease, Hashimoto's Disease, Pulmonary Embolism, Vasculitis, Graves' Disease, Polymyositis/Dermatomyositis, Rheumatic Heart Disease, Chronic Lymphocytic Thyroiditis, Polyarteritis
Ask a Question
Related Condition Support Groups
Related Drug Support Groups
prednisone, Acthar, Acth, Sandoglobulin, Octagam, Deltasone, Acthar Gel, HP, Flebogamma, Sterapred, view more... Privigen, Polygam S/D, Carimune, Sterapred DS, Liquid Pred, Gamimune N 10%, Gamimune, Panglobulin, Iveegam En, Carimune NF, Gammaplex, Gamimune N 5%, Gammagard S/D, Orasone, Meticorten, Panglobulin NF, immune globulin intravenous, Prednicen-M, Prednicot, Venoglobulin-S 10%, Venoglobulin-S 5%, corticotropin, Gammar-P IV